Has Douglas Cohen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,757 in general payments to Douglas Cohen, MD across 73 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Douglas Cohen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Douglas Cohen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Douglas Cohen, MD

Neurological Surgery · New York, NYNPI 1275549305

Payments from drug & device makers

$7,757in general payments, 2019–2025

Across 73 payments — averaging $106.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$5K
Brainlab, Inc.$1K
Globus Medical$598
Medtronic$527
Johnson & Johnson$263
Amgen$123

What the payments were for

Travel & lodging$3,78649%
Food & beverage$3,97151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	50	$5,143
Brainlab, Inc.	7	$1,102
Globus Medical(2 entities)	6	$598
Medtronic(2 entities)	4	$527
Johnson & Johnson	5	$263
Amgen	1	$123

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,757 in reported general payments places this provider in the 60th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York →

Medicare billing

Part B allowed, 2024

$54,328

Medicare patients

161

Services billed

300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclobenzaprine Hcl	45	$179
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	16	$71
Naproxen	27	$62
Ibuprofen	15	$40
Meloxicam	14	$20

Paid to pharmacies, not to this prescriber.

Other neurological surgery in New York

J MoccoNew York$16.3M
Christopher KellnerNew York$1.8M
Alejandro BerensteinNew York$1.3M
Gordon BaltuchNew York$1.2M
Shahram MajidiNew York$1.1M
Michael KaplittNew York$939K
Jan-Karl BurkhardtNew York$929K
Darryl LauNew York$916K
Mark BilskyNew York$903K
Reade DeleacyNew York$888K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →